Nature Communications (May 2024)

Small molecule induced STING degradation facilitated by the HECT ligase HERC4

  • Merve Mutlu,
  • Isabel Schmidt,
  • Andrew I. Morrison,
  • Benedikt Goretzki,
  • Felix Freuler,
  • Damien Begue,
  • Oliver Simic,
  • Nicolas Pythoud,
  • Erik Ahrne,
  • Sandra Kapps,
  • Susan Roest,
  • Debora Bonenfant,
  • Delphine Jeanpierre,
  • Thi-Thanh-Thao Tran,
  • Rob Maher,
  • Shaojian An,
  • Amandine Rietsch,
  • Florian Nigsch,
  • Andreas Hofmann,
  • John Reece-Hoyes,
  • Christian N. Parker,
  • Danilo Guerini

DOI
https://doi.org/10.1038/s41467-024-48922-w
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its’ involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.